Resveratrol, A Neuroprotective Supplement for Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|1|27-33

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.1, 2012-01, pp. : 27-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotective Therapies for Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 705-717

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's Disease-Associated Neurotoxic Mechanisms and Neuroprotective Strategies

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 4, 2005-08 ,pp. : 383-403

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotective Role of Nanoparticles Against Alzheimer's Disease

By  

Current Drug Metabolism, Vol. 17, Iss. 2, 2016-02 ,pp. : 142-149

Bentham Science Publishers

Access to resources Recommend Favorite

An Overview on Potential Neuroprotective Compounds for Management of Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-12 ,pp. : 1006-1011

Bentham Science Publishers

Access to resources Recommend Favorite

Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer’s Disease

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 17, 2016-07 ,pp. : 1951-1960

Bentham Science Publishers

Access to resources Recommend Favorite